About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
11
As Collaborator
1
Total Enrollment
3,000
By Phase
PHASE2: 9PHASE3: 3
By Status
COMPLETED: 8ACTIVE_NOT_RECRUITING: 2UNKNOWN: 1WITHDRAWN: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06565611Lead Sponsor
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
PHASE2Active, not recruiting
108 participants
Started: Aug 5, 2024 · Completed: Mar 31, 2025
NCT05709444Lead Sponsor
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
PHASE2Completed
16 participants
Started: Dec 26, 2022 · Completed: Apr 26, 2024
NCT05466890Lead Sponsor
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
PHASE2Active, not recruiting
16 participants
Started: Sep 15, 2022 · Completed: Mar 31, 2025
NCT05201170Lead Sponsor
A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye
PHASE3Completed
575 participants
Started: Dec 30, 2021 · Completed: Nov 21, 2023
NCT04318145Lead Sponsor
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
PHASE2Unknown
55 participants
Started: Nov 12, 2020 · Completed: Mar 31, 2023
Locations (1)
Headquarters
Cranbury, NJ, United States
Map
Loading map...